Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-08-15
2000-02-01
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 4242011, 4242081, 4242541, 4242821, 514 2, A01N 3718
Patent
active
060199792
ABSTRACT:
There is disclosed a method for anti-viral therapy treatment with the Pertussis toxin beta subunit oligomer, wherein the oligomer is composed of from two to ten subunits of PTX selected from the group consisting of S2, S3, S4, S5, and combinations thereof.
REFERENCES:
Locht and Keith Science 232:1258-1264, 1986.
Rosoff et al., J. Immunol. 139:2419-2423, 1987.
Rogers et al., J. Immunol. 145:678-683, 1990.
Ui, "Pertussis Toxin as a Valuable Probe for G-Protein Involvement in Signal Transduction".
Chong et al. Infection Immunity 60:4640-4647, 1992.
Wong and Rosoff, Can. J. Physiol. Pharmacol. 74:559-564, 1996.
Oka et al., "Enhancing Effects of Pertussis Toxin B Oligomer on the Immunogenicity of Influenza Vaccine Administered Intranasally", Vaccine, vol. 12, No. 14(1994), pp. 1255-1258.
Kenealy et al. "Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in Animals", AIDS Research and Human Retroviruses, vol. 5, No. 2(1989), pp. 173-182.
Chowdhury et al. "Pertussis Toxin Inhibits Induction of Human Immunodeficiency Virus Type 1 in Infected Monocytes" Virology, vol. 203, No. 2(Sep. 1994), pp. 378-383. QR1.V5.
Alfano Massimo
Bukrinsky Michael
Stucker Jeffrey
The Picower Institute for Medical Research
LandOfFree
Anti-viral treatment with pertussis toxin B oligomer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-viral treatment with pertussis toxin B oligomer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral treatment with pertussis toxin B oligomer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-935215